Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients
Journal of Neuro-Oncology · 2023
DOI: 10.1007/s11060-023-04413-4 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Neuro-Oncology, 2023. Verfasst von Eric J Lehrer und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. lehrer.eric@mayo.edu. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Radiosurgery, Lung Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Approximately 80% of brain metastases originate from non-small cell lung cancer (NSCLC). Immune checkpoint inhibitors (ICI) and stereotactic radiosurgery (SRS) are frequently utilized in this setting. However, concerns remain regarding the risk of radiation necrosis (RN) when SRS and ICI are administered concurrently. METHODS: A retrospective study was conducted through the International Radiosurgery Research Foundation. Logistic regression models and competing risks analyses were utilized to identify predictors of any grade RN and symptomatic RN (SRN). RESULTS: The study included 395 patients with 2,540 brain metastases treated with single fraction SRS and ICI across 11 institutions in four countries with a median follow-up of 14.2 months. The median age was 67 years. The median margin SRS dose was 19 Gy; 36.5% of patients had a V12 Gy ≥ 10 cm3. On multivariable analysis, V12 Gy ≥ 10 cm3 was a significant predictor of developing any grade RN (OR: 2.18) and SRN (OR: 3.95). At 1-year, the cumulative incidence of any grade and SRN for all patients was 4.8% and 3.8%, respectively. For concurrent and non-concurrent groups, the cumulative incidence of any grade RN was 3.8% versus 5.3%, respectively (p = 0.35); and for SRN was 3.8% vs. 3.6%, respectively (p = 0.95). CONCLUSION: The risk of any grade RN and symptomatic RN following single fraction SRS and ICI for NSCLC brain metastases increases as V12 Gy exceeds 10 cm3. Concurrent ICI and SRS do not appear to increase this risk. Radiosurgical planning techniques should aim to minimize V12 Gy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. lehrer.eric@mayo.edu.
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. lehrer.eric@mayo.edu.
- Department of Medical Oncology, Miami Cancer Institute, Miami, FL, USA.
- Department of Radiation Oncology, NYU Langone Medical Center, New York, NY, USA.
- Department of Neurosurgery, NYU Langone Medical Center, New York, NY, USA.
- Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Zitieren
APA
Lehrer, E. J., Khosla, A. A., Ozair, A., Gurewitz, J., Bernstein, K., Kondziolka, D., Niranjan, A., Wei, Z., Lunsford, L. D., Mathieu, D., Trudel, C., Deibert, C. P., Malouff, T. D., Ruiz-Garcia, H., Peterson, J. L., Patel, S., Bonney, P., Hwang, L., Yu, C., …, & Ahluwalia, M. S. (2023). Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-023-04413-4
Vancouver
Lehrer EJ, Khosla AA, Ozair A, Gurewitz J, Bernstein K, Kondziolka D, et al. Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients. Journal of Neuro-Oncology. 2023. doi:10.1007/s11060-023-04413-4
BibTeX
@article{Lehrer2023,
author = {Lehrer, Eric J and Khosla, Atulya A and Ozair, Ahmad and Gurewitz, Jason and Bernstein, Kenneth and Kondziolka, Douglas and Niranjan, Ajay and Wei, Zhishuo and Lunsford, L Dade and Mathieu, David and Trudel, Claire and Deibert, Christopher P and Malouff, Timothy D and Ruiz-Garcia, Henry and Peterson, Jennifer L and Patel, Samir and Bonney, Phillip and Hwang, Lindsay and Yu, Cheng and Zada, Gabriel and Picozzi, Piero and Franzini, Andrea and Attuati, Luca and Prasad, Rahul N and Raval, Raju R and Palmer, Joshua D and Lee, Cheng-Chia and Yang, Huai-Che and Fakhoury, Kareem R and Rusthoven, Chad G and Dickstein, Daniel R and Sheehan, Jason P and Trifiletti, Daniel M and Ahluwalia, Manmeet S},
title = {Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients},
journal = {Journal of Neuro-Oncology},
year = {2023},
doi = {10.1007/s11060-023-04413-4}
}
EUVIMED